Pharmacovigilance of Traditional Chinese Medicine in Pharmaceutical Care in Medical Institutions

doi:10.19803/j.1672-8629.2021.05.05

Abstract

Abstract: Objective To explore medical institutions carry out traditional Chinese medicine(TCM) pharmacovigilance practice combined with pharmaceutical service. Methods Through literature review and preliminary clinical research results, the current situation of pharmaceutical care and the problems of pharmacovigilance of TCM in medical institutions were mastered. Based on the results of pharmacovigilance of TCM in our research group, the risk of pharmacovigilance of TCM in pharmaceutical care posts was refined and practiced. Results Medical institutions were the basic units to implement pharmacovigilance in China, and their pharmaceutical care level is an important guarantee for the implementation of pharmacovigilance. Conclusion Attention should be paid to the role of pharmacovigilance of TCM in pharmaceutical care in medical institutions and strengthen the pharmacovigilance of Chinese medicine. A practical model should be established with clinical pharmacists in medical institutions as the main body and pharmacovigilance as the breakthrough point to carry out the whole-process pharmaceutical care.

Key words: medical institutions, traditional Chinese medicine(TCM), pharmacovigilance, pharmaceutical care

CLC Number:

R28R944.11

SA Rina, ZHANG Bing, LIN Zhijian, WANG Xiaofang, ZHANG Xiaomeng. Pharmacovigilance of Traditional Chinese Medicine in Pharmaceutical Care in Medical Institutions[J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 422-426.

References

[1] Zeng FD.Medical quality management and responsibility of clinical pharmacy[J].Herald of Medicine(医药导报),2017,36(11):1215-1218.
[2] Gao Y,An H,Xu MH,et al.Brief introduction to Chinese medicine pharmacovigilance[J].Chinese Journal of Basic Medicine in Traditional Chinese Medicine(中国中医基础医学杂志),2019,25(2):233-234.
[3] NHC National Health Commission of the People's Republic of China.statistical bulletin of health development in China 2019[EB/OL].(2020-06-06)[2021-01-15].http://www.nhc.gov.cn/guihuaxxs-s10748/202006/ebfe31f24cc145b198dd730603ec4442.shtml.
[4] Chinese Hospital Association.Notice on further strengthening the construction of clinical pharmacist system[EB/OL].(2016-11-28)[2021-01-15].http://www.cha.org.cn/plus/view.php?aid=15129.
[5] Zhou JF,Sun CJ.The development status and trend of hospital pharmacy service[J].Chinese Manipulation &Rehabilitation Medicine(按摩与康复医学),2021,12(2):83-86.
[6] Zhao N,Zhao R,Liu LH.Analysis on the current situation and requi-rements of pharmaceutical services in public hospitals in China[J].Clin-ical Medication Journal(临床药物治疗杂志),2020,18(11):78-81.
[7] National Health Commission of the People's Republic of China,National administration of traditional Chinese medicine.Opinions on accelerating the high quality development of pharmaceutical services[EB/OL].(2018-11-28)[2021-01-15].http://www.gov.cn/xinwen/2018-11/28/content_5344128.htm.
[8] Zhang B,Jin R,Wu JR.A course building of clinical Chinese medicine based on the knowledge framework of modern clinical pharmacists of Chinese medicine[J].Pharmaceutical Education(药学教育),2011,27(5):23-25.
[9] Wu JR,Zhang B.Discussion of traditional Chinese medicine pharmacovigilance[J].Chinese Journal of Pharmacoepidemiology(药物流行病学杂志),2009,18(5):312-315.
[10] Zhao X,Leng ML,Wang P,et al.Research on current status and countermeasures of information collection on adverse drug reactions by drug manufacturers from medical institutions in China[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2018,15(11):652-657.
[11] Feng YN,Liu XX,Li YH,et al.Challenges to pharmacovigilance by medical institutions under the new drug administration law[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2020,17(9):572-573.
[12] Sun XX.Analysis and thinking on the current situation of rational use of traditional chinese medicine based on the concept of pharmaceutical care(基于药学报务理念的基层医生中药合理用药现状分析与思考)[D].Beijing:Beijing University of Traditional Chinese Medicine,2017.
[13] Wang Y,Lin ZH,Dong YZ,et al.Investigation of pharmaceutical services for traditional Chinese medication precautions in medical institutions[J].China Pharmacist(中国药师),2018,21(12):2133-2139.
[14] Tian LJ.Research on the history of modern chinese pharmacy(中国现代药学史研究)[D].Shenyang:Shenyang Pharmaceutical University,2006.
[15] Chen F,Yang SM.Chen F,et al.Status and problems of ADR monito-ring system in china[J].Herald of Medicine(医药导报),2006(5):486-488.
[16] Lou S,Tang SL.Discussion on problems encountered by clinical pharmacists of traditional Chinese medicine and improvement measures[J].Pharmacy and Clinics of Chinese Materia Medica(中药与临床),2020,11(3):21-23.
[17] Guan G,Ru SS,Rong CL.Role and work connotation of clinical pharmacists in rational application of traditional Chinese medicine in primary Chinese medicine hospitals[J].Journal of Community Medicine(社区医学杂志),2018,16(21):1589-1591.
[18] Lin P,Ma KF,Song SZ,et al.Specification for pharmaceutical care in medical institutions Part 2 prescription review[J].China Pharmacy(中国药房),2019,30(23):3176-3177.
[19] Jin R,Zhang B.Theory and practice of comment on prescription of chinese patent medicine(中成药处方点评的理论与实践)[M].Beijing:People's Medical Publishing House,2019.
[20] Zhang B.Chinese medicine pharmacovigilance(中药药物警戒)[M].Beijing:People's Medical Publishing House,2015.
[21] Tan WJ,Jing ZH,Li QZ,et al.Specification for pharmaceutical care in medical institutions part 6 pharmaceutical ward round[J].China Pharmacy(中国药房),2019,30(24):3316-3318.
[22] Hou WJ,Pu YS,Jin ZH,et al.Specification for pharmaceutical care in medical institutions part 7 medication monitoring[J].China Pharamacy (中国药房),2019,30(24):3318-3321+3324.
[23] Yan XL,Dai TT,Wang CH,et al.Specification for pharmaceutical care in medical institutions part 3 medication reconciliation[J].China Pharamacy(中国药房),2019,30(23):3178-3180.
[24] Xin BW,Gu WY,Shi KR,et al.Discussion on the present situation of Chinese medicine consultation and medication education[J].World Latest Medicine Information(世界最新医学信息文摘),2019,19(96):269-270.
[25] Du LP,Fan P,Jing ZH,et al.Specification for pharmaceutical care in medical institutions part 5 medicine education[J].China Pharamacy(中国药房),2019,30(24):3315-3316.
[26] Yang LY,Du S,Li XY,et al.Specification for pharmaceutical care in medical institutions part 1 pharmacist-managed clinic[J].China Pharamacy(中国药房),2019,30(23):3174-3175.